变更部分募集资金用途的核查意见 中天国富证券有限公司（以下简称"中天国富证券"或"保荐机构"）作为山东 国瓷功能材料股份有限公司（以下简称"国瓷材料"或"公司"）向特定对象发行股 票的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市 公司自律监管指引第 13 号——保荐业务》《深圳证券交易所创业板股票上市规 则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》 等法律法规的要求，对国瓷材料变更部分募集资金用途相关事项进行了审慎核查， 核查情况及核查意见如下： 一、变更募集资金投资项目的概述 （一）募集资金基本情况 经中国证券监督管理委员会《关于同意山东国瓷功能材料股份有限公司向特 定对象发行股票注册的批复》（证监许可[2020]2945号）同意，国瓷材料向特定 对象发行A股人民币普通股股票40,469,279股，每股面值为人民币1.00元，发行 价格为20.67元/股，募集资金总额为836,499,996.93元，扣除与发行有关的费用 14,196,669.12元（不含税），公司实际募集资金净额 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2023-062 2023 年 8 月 11 日，国瓷康立泰与科达制造共同出资成立广东康立泰新材料 有限公司（以下简称"广东康立泰"），国瓷康立泰持股比例 49%，科达制造持股 比例 51%。根据其股东会决议，公司总经理霍希云女士出任广东康立泰董事职务， 并由 KAMI COLOURCERA PRIVATE LIMITED（以下简称"印度 KAMI"）、KAMI MATERIALS CO.,LIMITED(以下简称"香港 KAMI")和广东康立泰共同负责国瓷康立泰及其子 公司相关陶瓷墨水、陶瓷色釉料等产品在海外市场开拓和销售。按照《深圳证券 交易所创业板股票上市规则》的规定，公司将追加广东康立泰为关联方，国瓷康 立泰及其子公司与印度 KAMI、香港 KAMI、广东康立泰之间的交易事项构成日常 关联交易。 山东国瓷功能材料股份有限公司 关于追加关联方及 2023 年度日常关联交易预计额度的公告 本公司及董事会全体人员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司(以下简称"公司"或"国瓷材料")于 2 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2023-059 山东国瓷功能材料股份有限公司 第五届监事会第十次会议决议公告 本公司及监事会全体人员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于 2023 年 10 月 22 日以邮件形式发出了《第五届监事会第十次会议的通知》。本次会议于 2023 年 10 月 25 日在公司会议室以现场会议和通讯会议的方式召开。会议应出席监事 3 名， 实际出席监事 3 名。本次会议的召集、召开符合《公司法》及《公司章程》的有关规 定，会议合法有效。本次会议由监事会主席温长云先生主持。 本次监事会对以下议案内容进行了表决，表决情况如下： 一、审议通过了《关于公司 2023 年第三季度报告的议案》 经审核，监事会认为：董事会编制和审核《公司2023年第三季度报告》的程序 符合法律、行政法规、中国证监会和深圳证券交易所的相关规定，报告内容真实、 准确、完整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大 遗漏。 具 体 内 容 详 见 中 国 证 监 会 指 定 ...

山东国瓷功能材料股份有限公司 证券代码：300285 证券简称：国瓷材料 公告编号：2023-055 一、对外投资概述 为了扩充公司在义齿加工领域的产品线，构建产品优势、增强协同研发能力 以及公司全球化的战略发展目标，山东国瓷功能材料股份有限公司（以下简称"公 司"或"国瓷材料"）的全资孙公司 SINOCERA (SINGAPORE) PTE.LTD.（以下简 称 " 国 瓷 新 加 坡 "） 以 自 有 资 金 1,350.4217 万 欧 元 对 德 国 DEKEMA Dental-Keramiköfen GmbH （以下简称"DEKEMA"或"目标公司"）进行投资。 2023年5月16日（北京时间），国瓷新加坡与目标公司的母公司DEBROS GmbH （以下简称"DEBROS"）签署了一系列协议。根据相关协议约定，国瓷新加坡将 受让 DEBROS 持有的目标公司74.9%股权。本次股权转让完成后，国瓷新加坡将 持有目标公司74.9%的股权。 具体内容详见公司于2023年5月18日在中国证监会指定的创业板信息披露网 站巨潮资讯网上披露的《关于全资孙公司对外投资购买境外股权的公告》（公告 编号：2023-0 ...

证券代码：300285 证券简称：国瓷材料 山东国瓷功能材料股份有限公司 投资者关系活动记录表 编号：DY2023-008 投资者关系 活动类别 □特定对象调研 分析师会议 □媒体采访 业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他（请文字说明其他活动内容） 参与单位名 称及人员姓 名 线上参与本次年度业绩说明会的投资者 时间 2023 年 9 月 22 日下午 15:00-17:00 地点 全景网"投资者关系互动平台"（http://ir.p5w.net） 上市公司接 待人员姓名 总经理：霍希云女士 副总经理兼董事会秘书：许少梅女士 副总经理兼财务总监：肖强先生 独立董事：李济东先生 投资者关系 活动主要内 容介绍 公司于2023年8月9日在巨潮资讯网披露了《2023年半年度报告》，为让 广大投资者进一步了解公司2023年半年度经营情况，公司于2023年9月22日 （周五）15:00-17:00在全景网举办2023年半年度业绩说明会。本次半年度业 绩说明会采用网络远程的方式举行。主要内容如下： 1、去年中期业绩开始下降时大股东减持是否有知情人交易，大股东是否开 通转融通业务？ 今年溢价收购赛创电气 ...

为充分尊重投资者、提升交流的针对性，现就本次业绩说明会提前向投资者 公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 9 月 21 日 （周四）17:00 前访问 https://ir.p5w.net/zj/，或扫描下方二维码，进入问题 征集专题页面。公司将在本次业绩说明会上，对投资者普遍关注的问题进行回答。 证券代码:300285 证券简称:国瓷材料 公告编号:2023-053 山东国瓷功能材料股份有限公司 关于举行 2023 年半年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司(以下简称为"公司")为便于广大投资者更 加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2023 年 9 月 22 日 （星期五）15:00-17:00 在全景网举办 2023 年半年度业绩说明会，本次业绩说明 会将采用网络远程的方式举行，投资者可登录全景网"投资者关系互动平台" （https://ir.p5w.net/）参与本次说明会。 出席本次说明会的人员有:公司总经理霍希云女士、副总经理兼董事会秘书许 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2023-052 山东国瓷功能材料股份有限公司 关于公司第一大股东股权解除质押及新质押的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于近日 收到公司第一大股东张曦先生的通知，获悉张曦先生将其所持有的部分国瓷材 料股份办理了解除质押及新质押等相关业务。具体情况如下： | 股东名称 | 是否为公司第一 大股东或实际控 | 解除质押股数 | 占其所持股份 比例 | 占公司总股本 比例 | 质押开始日期 | 解除质押日期 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 制人 | （股） | | | | | | | 张曦 | 是 | 2,500,000 | 1.232% | 0.249% | 2023-03-27 | 2023-08-29 | 华泰证券（上海） 资产管理有限公司 | | 张曦 | 是 | 2,500,000 | 1.232% | 0.249% | 2023-03 ...

证券代码：300285 证券简称：国瓷材料 公告编号：2023-050 山东国瓷功能材料股份有限公司 二、股东股份质押情况 1、本次股份质押基本情况 | 股东 名称 | 是否为公 司第一大 股东或实 | 本次质押数 量（股） | 占其所持股 份比例 | 占公司总 股本比例 | 是否为 限售股 | 是否为 补充质 押 | 质押开始日期 | 质押到期日 | 质权人 | 用途 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 际控制人 | | | | | | | | | | | 张曦 | 是 | 5,080,000 | 2.504% | 0.506% | 否 | 否 | 2023-08-17 | 2024-08-17 | 中信证券股 份有限公司 | 融资 | 关于公司第一大股东股权解除质押及新质押的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 山东国瓷功能材料股份有限公司（以下简称"公司"或"国瓷材料"）于近日 收到公司第一大股东张曦先生的通知，获悉张曦先生将其所持有 ...

Financial Performance - In the first half of 2023, the company achieved operating revenue of 1.85 billion CNY, an increase of 6.91% compared to the same period last year [1] - The net profit attributable to shareholders was 319 million CNY, a decrease of 20.83% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 283 million CNY, down 22.14% year-on-year [1] - In Q2 2023, the net profit attributable to shareholders was 195 million CNY, with a quarter-on-quarter increase of 58% [1] - The net profit after deducting non-recurring gains and losses in Q2 was 182 million CNY, with a quarter-on-quarter increase of 81% [1] Business Segment Performance - **Electronic Materials**: Sales of MLCC dielectric powder products improved quarter-on-quarter [1] - **Catalytic Materials**: Synergistic effects began to show, with significant growth in products like honeycomb ceramics and cerium-zirconium solid solutions [1] - **Biomedical**: Accelerated overseas expansion, including an investment in DEKEMA in Germany, beneficial for the dental equipment sector [1] - **New Energy Materials**: Rapid increase in sales of alumina and barium stone, with a reduction in sales prices after cost improvements [1] - **Precision Ceramics**: The company is seizing opportunities in the application of ceramic bearing balls for 800V high-voltage fast-charging electric vehicles [1] Market Outlook and Investor Q&A - The MLCC dielectric material business is recovering, with a cautious optimism about industry recovery as downstream inventory returns to reasonable levels [2] - The dental business is expected to maintain stable growth annually, focusing on multiple product lines, internationalization, and high-end branding [2] - Recent anti-corruption measures in the medical industry have not impacted the dental business, as products primarily enter public hospitals through public bidding and agency methods [2] - The company is actively preparing for new production capacity in the cerium-zirconium product line, focusing on domestic substitution and international cooperation [3]

Financial Performance - The company reported a revenue of 1.2 billion CNY for the first half of 2023, representing a year-on-year increase of 15%[7]. - The net profit attributable to shareholders reached 200 million CNY, up 10% compared to the same period last year[7]. - The company's operating revenue for the first half of 2023 was CNY 1,850,367,737.30, representing a 6.91% increase compared to the same period last year[12]. - Net profit attributable to shareholders decreased by 20.83% to CNY 318,950,205.33, while the net profit after deducting non-recurring gains and losses fell by 22.14% to CNY 283,172,775.66[12]. - The total comprehensive income for the first half of 2023 was CNY 351,024,534.44, compared to CNY 410,450,241.78 in the previous year, indicating a decrease of 14.4%[150]. - The basic earnings per share for the first half of 2023 was CNY 0.32, down from CNY 0.40 in the same period last year[150]. - The company's total operating costs increased to CNY 1,471,889,931.34, up from CNY 1,283,626,288.53, representing a rise of 14.7%[149]. - The company reported a significant increase in sales expenses by 34.73% to ¥91,961,271.25, attributed to higher wages, travel, and exhibition costs[49]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 20% market share by 2025[7]. - Future guidance estimates a revenue growth of 12-15% for the second half of 2023, driven by increased demand in the electronics sector[7]. - The company is exploring potential mergers and acquisitions to enhance its product portfolio and market reach[7]. - The company has strategically acquired Germany's Dekema, a leading company in the global dental sintering equipment sector, enhancing its product pipeline and high-end brand offerings in the dental field[23]. - The company is actively involved in the research and development of new dental materials, enhancing its competitive position in the market[37]. Research and Development - Research and development expenses increased by 30%, totaling 150 million CNY, focusing on innovative materials and technologies[7]. - The company plans to continue increasing R&D investment and accelerate capacity expansion, focusing on cultivating high-capacity electronic paste products for automotive applications[20]. - The company has established a robust quality management system for medical devices, ensuring compliance with international standards[31]. - The company is enhancing its research and development capabilities through the establishment of independent platforms and collaboration with technology research institutes, aiming for high-quality development[28]. Financial Position and Assets - The company's total assets increased by 11.39% to CNY 8,356,061,879.32 compared to the end of the previous year[12]. - The company's total equity attributable to shareholders rose to CNY 6,104,190,616.00 from CNY 5,882,401,887.05, reflecting an increase of about 3.77%[145]. - The company's cash and cash equivalents decreased to CNY 535,353,550.58 from CNY 566,164,012.26, a decline of approximately 5.67%[143]. - The company's total liabilities increased to CNY 1,800,520,574.53 from CNY 1,196,466,847.64, representing a growth of approximately 50.51%[145]. Environmental Compliance and Sustainability - The company and its subsidiaries strictly comply with various environmental protection laws and standards, including the Comprehensive Emission Standard of Air Pollutants (GB16297-1996)[82]. - The company has conducted environmental impact assessments for construction projects in accordance with legal requirements, ensuring compliance with environmental protection regulations[84]. - The company has implemented measures for carbon emission management, focusing on energy and resource consumption monitoring through an "Industrial Internet" management model[99]. - In the first half of 2023, the company invested over 30 million yuan in environmental protection, achieving pollution reduction effects[97]. Risk Management - Risk factors identified include fluctuations in raw material prices and potential regulatory changes impacting operations[2]. - The company faces risks from fluctuations in raw material prices, which are a major component of production costs, potentially leading to decreased gross margins and profit levels if prices rise without corresponding product price increases[73]. - The company has established a comprehensive management system for accounts receivable, including monitoring payment timeliness and analyzing overdue accounts to mitigate collection risks[75]. - The company employs various hedging strategies to minimize foreign exchange losses and renegotiates pricing with clients when exchange rates fluctuate significantly[76]. Corporate Governance and Compliance - The company has not implemented any stock incentive plans or employee stock ownership plans during the reporting period[80]. - The company has no overdue projects without environmental permits and adheres to pollution discharge standards[86]. - The company has not engaged in poverty alleviation or rural revitalization efforts during the reporting period, nor does it have plans for such initiatives[100]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[106]. Subsidiaries and Investments - The subsidiary Wangzi Ceramics reported a net profit of RMB 59.57 million, contributing significantly to the overall performance[69]. - The company has established two new subsidiaries, Maijie Technology and Maituo Technology, with no significant impact on overall operations[70]. - The company completed a significant equity investment in Spident, acquiring a 20.03% stake for ¥38,674,943.69, with an expected return of ¥5,818,543.05[58]. - The company’s subsidiary, Guoci Singapore, plans to invest 1,350.4217 million Euros to acquire 74.9% of DEKEMA Dental-Keramiköfen GmbH[121].